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Polyclonal antibodies were raised against the membrane-bound penicillin-binding protein (PBP 2’) present 
in methicillin-resistant strains of Staphylococcus uureus (MRSA) and were used to detect its presence in 
membranes from strains grown under varying conditions for the expression of resistance. The antibody 
preparation reacted with another membrane protein from methicillin-sensitive S. aureuz (MSSA) which mi- 
grated to the same position as PBP 2’ on SDS gel electrophoresis. Pretreatment of the antisera with mem- 
branes of sensitive strains removed antibodies recognising high-M, proteins common to both MRSA and 
MSSA: the residual antibody then reacted specifically with PBP 2’. Antisera pretreated in this manner can 
be used as a probe for the definitive identi~~tion of MRSA strains. 
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1. INTRODUCTION 
The introduction into clinical use of #-lactam 
antibiotics such as methicillin and cioxacillin that 
are resistant o hydrolysis by fl-lactamases resulted 
in the appearance in the hospital environment of 
methicillin-resistant strains of Staphyiococcus 
aureus (MRSA). These strains were first isolated in 
Britain 111, then in the rest of Europe in which in- 
cidences of 7-20% were reported and more recent- 
ly from many parts of the world including 
Australia, Japan and the USA. Some of the more 
recently isolated strains are not only resistant o ,& 
lactam antibiotics but also have chromosomal and 
plasmid-determined resistances to many other an- 
tibiotics in clinical use. In several instances van- 
comycin and similar compounds have been shown 
to be the only antibiotics to which these strains are 
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susceptible. Naturally occurring P-lactamase- 
negative (p-) strains of S. aweus have been 
isolated which retain their resistance to methicillin 
(m’) confirming that production of ,&lactamase is 
not the mechanism ‘by which these strains have 
achieved their resistance to &lactams [2]. 
Intrinsic resistance in MRSA strains was later at- 
tributed to the presence of a completely novel, ad- 
ditional PBP (termed PBP 2’ because its mobility 
on SDS gel el~trophoresis is inte~ediate between 
those of PBP 2 and PBP 3) which is produced in 
large amounts [3,4], has a greatly reduced affinity 
for ,B-lactam antibiotics in comparison with the 
other three high-M, PBPs [5-81 and is the sole 
functional PBP when MRSA strains are grown in 
the presence of high concentrations of &lactam 
antibiotics that would kill sensitive strains 161. Par- 
tial proteolysis of the complex of the additional 
PBP with radiolabelled penicillin revealed that 
peptides containing the active site are different 
from those derived from PBPs present in sensitive 
strains [9], indicating that the additional PBP is 
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unlikely to have been derived from an existing PBP 
and that the gene encoding it has presumably been 
acquired from a different organism. 
Furthermore, identical peptides were derived 
from MRSA strains isolated from several different 
sources, suggesting that the same additional PBP is 
present in all MRSA strains [9]. 
were added and incubation continued for a further 
15 min. Membranes were collected by centrifuga- 
tion at 40000 x g for 20 min at 4”C, washed and 
resuspended in 10 mM phosphate buffer, pH 7.2. 
Membranes were resuspended at 10 mg protein/ml 
and stored at - 30°C. Labelling of PBPs was car- 
ried out as described in [14]. 
The detection and comparison of PBPs involve 
labelling of intact cells or membranes with a 
radiolabelled fl-lactam, followed by fractionation 
of the proteins on slab gels by SDS-polyacrylamide 
gel electrophoresis (SDS-PAGE) and preparation 
of the gel for fluorography. Detection of PBPs by 
this technique requires several days exposure of the 
X-ray film and in the special case of PBP 2’ con- 
siderable expense is involved because high concen- 
trations of radiolabelled benzylpenicillin are 
required to saturate the PBP because of its very 
low affinity for &lactam antibiotics. An alter- 
native method has been used to reveal PBPs in a 
number of different bacteria involving the use of 
antibodies prepared against the benzylpenicilloyl 
determinant [lo] or against partially purified PBPs 
[ 11,121. A rapid and sensitive method is described 
here for visualising PBP 2’ of MRSA strains 
specifically, by Western blotting and immuno- 
overlay techniques using an antibody raised 
against the protein after electroelution from SDS 
gels. 
2.3. Electroelution of PBP 2 ’ 
Membrane proteins were separated by SDS- 
PAGE on preparative slab gels and revealed by 
light staining with Coomassie blue. The band cor- 
responding to PBP 2’ was carefully excised [15] 
and PBP 2’ electroeluted for 5 h at 100 V. The 
electroeluted material containing PBP 2’) any 
other protein having the same mobility, SDS and 
Coomassie blue was carefully removed from the 
dialysis sac and stored at - 30°C. 
2.4. Immunisation procedure 
2. MATERIALS AND METHODS 
New Zealand White rabbits were immunised 
with PBP 2’ which had been electroeluted from 
gels. The initial injection containing 300 fig protein 
mixed with an equal volume of Freunds complete 
adjuvant and was administered subcutaneously at 
three different sites. Subsequent boosts were given 
every 2 weeks using 100,~g protein mixed with 
Freunds incomplete adjuvant. 20 ml blood was 
removed at the time of each boost and the antisera 
prepared and stored at -30°C in the presence of 
0.02% azide. 
2.1. Bacterial strains and growth conditions 2.5. Western blotting and immunological 
Two isogenic strains of S. aureus lacking ,&- 
lactamase were used, 13 136 p-m+ (methicillin- 
resistant) and 13 136 p-m- (sensitive) [13]. The 
resistant strain was grown at 30°C in a rich 
medium [3] containing 5% NaCl and methicillin 
(5 mg/l), conditions favouring the expression of 
resistance and of PBP 2’. The sensitive strain was 
grown at 37°C in the absence of NaCl and of an- 
tibiotic. 
detection 
2.2. Preparation of membranes 
Exponentially growing organisms were 
harvested, washed in 50 mM Tris-HCl, 145 mM 
NaCl, pH 7.5, and resuspended at 30 mg dry 
wt/ml in the same buffer containing lysostaphin 
(20 mg/l). The suspension was incubated at 37°C 
for 15 min, 10 mM MgCL and DNase (30 mg/l) 
Proteins were subjected to SDS-PAGE [16] 
under conditions giving increased resolution of the 
high-ill, PBPs [6]. The separated proteins were 
transferred electrophoretically onto nitrocellulose 
and visualised by an enzyme-linked immunological 
development [171. Optimum transfer of proteins 
was achieved by blotting at 100 mA for approx. 
150 V - h. Antisera was used at a dilution of 1: 100 
and incubated with the nitrocellulose for 2-3 h. 
Non-specific binding was prevented by pretreating 
the nitrocellulose after blotting with casein in Tris- 
buffered saline (TBS), pH 7.2, for 1 h; this block- 
ing buffer was included in subsequent antibody in- 
cubations after which excess antibody was 
removed by several washings in TBS alone. The 
second antibody was a peroxidase-conjugated anti- 
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rabbit antibody used at a dilution of 1: 1000 for 
1 h. Development of the blotted proteins was 
achieved by soaking the nitrocellulose in TBS, pH 
7.2, containing 4-chloro-1-naphthol (0.6 mg/ml), 
5% methanol and 0.01% H202. The reaction was 
quenched by washing in distilled water. 
2.6. Fluorography 
After separation by SDS-PAGE, PBPs were 
visualised by fluorography [ 181. Labelled PBPs 
bound to nitrocellulose were revealed by process- 
ing the membrane filter as in 1191. 
3. RESULTS AND DISCUSSION 
Antisera against the high% PBP 2’ present in 
MRSA but not MSSA strains were raised in rabbits 
using as antigen PBP 2 ’ (M 78000) that had been 
separated from the other membrane proteins by 
SDS-PAGE, followed by electroelution. The elec- 
troeluted material gave a single Coomassie blue- 
staining band on SDS-PAGE, though the large 
amount of PBP 2 ’ present could have concealed 
other minor protein bands having the same mobili- 
ty. The antibody preparation was tested against 
membrane proteins of MRSA and MSSA strains, 
pre-labelled with [3H]benzylpenicillin (30 mg/l), 
that had been separated by SDS-PAGE and 
transferred to nitrocellulose by Western blotting. 
Rabbit antisera produced after 6-8 weeks reacted 
with a protein band of 78 kDa that was present in 
membranes from both methicillin-sensitive and 
-resistant strains (fig.l(I)). It is probable that the 
immunogen contained two 78 kDa proteins, one of 
which was PBP 2’, both being electroeluted from 
the excised band of polyacrylamide gel. The an- 
tibody recognising the other cont~inating protein 
that was not a PBP was removed by preadsorption 
of the antisera to membranes from the isogenic 
sensitive strain. Membranes of 13 136 p-m- (10 mg 
protein) were resuspended in 500~1 antisera and 
incubated with shaking at room temperature for 
20 min: the membranes and immunoprecipitated 
antibodies were removed by centrifugation and the 
residual antisera re-tested. After this treatment he 
antisera reacted only with a 78 kDa protein present 
in membranes from the methicillin-resistant strain 
and with electroeluted material used as the antigen 
(fig.l(II)). Preadsorption of the polyclonal an- 
tibody preparation to sensitive membranes is 
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Fig.1. Immunoblot of proteins separated by SDS- 
PAGE, transferred onto nitrocellulose and probed with 
a polyclonal antibody raised against electroeluted PBP 
2’. Rabbit antisera (I) were preadsorbed to sensitive 
membranes and the remaining supernatant tested (II); 
the solution containing antibodies after adsorption to 
sensitive membranes was followed by incubation with 
resistant membranes, the residual antisera being tested 
(IV). Antisera preadsorbed to resistant membranes only 
were assayed for remaining antibodies (III). All primary 
antibody incubations were carried out at a dilution of 
1: 100. Tracks A and B contained membrane proteins 
prepared from MSSA and MRSA respectively, whilst 
track C contained PBP 2’ which had been electroeluted 
from preparative SDS polyacrylamide gels. 
therefore a necessary step in removing antibodies 
recognising high-&f, proteins common to MRSA 
and MSSA strains before it can be used to detect 
PBP 2’ specifically. 
At a dilution of 1: 100 the antibody could still 
detect the small amourn of PBP 2’ present in 
membranes of MRSA strains grown under condi- 
tions unfavourable for the expression of 
resistance. It is technic 
“f 
ly difficult to detect such 
small amounts of PBP : 2’ by conventional PBP 
assays without using high concentrations of expen- 
sive radiolabelled penicillin and improved separa- 
tion techniques [6]. This suggests that the 
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immunological detection method described here 
has a greater sensitivity and specificity compared 
with the conventional method of detection of PBP 
2’. Furthermore, the method is also more reliable 
in the identification of MRSA strains than the 
techniques currently used in clinical micro- 
biological laboratories. 
The use of nitrocellulose permits the detection of 
radiolabelled PBPs after immunological identifica- 
tion of PBP 2’) therefore allowing direct com- 
parisons of bands seen on the immunoblot with 
those on the fluorogram (fig.2). This permits the 
definitive identification of the 78 kDa band reac- 
ting with the antibody as PBP 2’) the PBP found 
uniquely in methicillin-resistant staphylococci. 
As the 78 kDa protein that was not PBP 2’ 
could be immunoprecipitated with membranes of a 
sensitive strain it was considered that the antibody 
A B 
PBP 
Fig.2. Membrane proteins from 13136 p-m+ were 
radiolabelled, separated by SDS-PAGE and transferred 
onto a nitrocellulose membrane as described in section 2. 
Antisera preadsorbed to membranes from 13136 p-m- 
were used at a dilution of 1: 100 (A) and the PBPs were 
revealed by fluorography (B). 
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might react with PBP 2’ in its native state (i.e. in 
membranes from the resistant strain) even though 
it was raised against denatured PBP 2’. However, 
although electroeluted PBP 2’ partially retained its 
ability to bind radiolabelled benzylpenicillin and 
therefore presumably retained its native conforma- 
tion, the antibody raised against it was not im- 
munoprecipitated by membranes from resistant 
strains (fig. l(III)-(IV)). 
The antibody preparation has also been used to 
demonstrate the presence of PBP 2’ in methicillin- 
resistant strains of S. epidermidis, though the 
strains examined did not produce large amounts of 
the protein even when grown in the presence of fl- 
lactam antibiotics. 
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